@article{a789a93b161348f0abf6aab2bfe9dd6f,
title = "Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18] FDG-PET in patients with newly diagnosed metastatic renal cell carcinoma",
author = "S. Verhoeff and \{van Es\}, \{S. C.\} and E. Boon and \{van Helden\}, E. and L. Angus and Elias, \{S. G.\} and Oosting, \{S. F.\} and Aarntzen, \{E. H.\} and Brouwers, \{A. H.\} and Kwee, \{T. C.\} and S. Heskamp and Hoekstra, \{O. S.\} and H. Verheul and Zwezerijnen, \{G. J. C.\} and \{van Oordt\}, \{C. Menke-van der Houven\} and \{van der Veldt\}, \{A. A. M.\} and \{de Vries\}, \{E. G. E.\} and Boerman, \{O. C.\} and \{van der Graaf\}, \{W. T. A.\} and Oyen, \{W. J. G.\} and \{van Herpen\}, \{C. M. L.\}",
year = "2019",
month = oct,
language = "English",
volume = "46",
pages = "S67",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer",
number = "SUPPL 1",
note = "32<sup>nd</sup> Annual Congress of the European Association of Nuclear Medicine (EANM), EANM{\textquoteright}19 ; Conference date: 12-10-2019 Through 16-10-2019",
url = "https://www.eanm.org/congresses-events/past-congresses/congresses-overview/, http://Barcelona, Spain CME, EANM, 15 okt 2019",
}